File Download
 
Links for fulltext
(May Require Subscription)
  • Find via
 
Supplementary

Conference Paper: Interim report on a phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in Chinese patients with chronic hepatitis B infection
  • Basic View
  • Metadata View
  • XML View
TitleInterim report on a phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in Chinese patients with chronic hepatitis B infection
 
AuthorsYuen, RMF
Kim, J
Wong, DKH
Ngai, WS
Yuen, JCH
Lai, CL
 
Issue Date2004
 
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
 
CitationJournal of Hepatology, v. 40 n. suppl 1, p. 133 [How to Cite?]
 
ISSN0168-8278
2013 Impact Factor: 10.401
 
DC FieldValue
dc.contributor.authorYuen, RMF
 
dc.contributor.authorKim, J
 
dc.contributor.authorWong, DKH
 
dc.contributor.authorNgai, WS
 
dc.contributor.authorYuen, JCH
 
dc.contributor.authorLai, CL
 
dc.date.accessioned2010-09-25T19:48:54Z
 
dc.date.available2010-09-25T19:48:54Z
 
dc.date.issued2004
 
dc.identifier.citationJournal of Hepatology, v. 40 n. suppl 1, p. 133 [How to Cite?]
 
dc.identifier.hkuros130911
 
dc.identifier.issn0168-8278
2013 Impact Factor: 10.401
 
dc.identifier.issuesuppl 1
 
dc.identifier.openurl
 
dc.identifier.spage133
 
dc.identifier.urihttp://hdl.handle.net/10722/101419
 
dc.identifier.volume, v. 40 n. suppl 1
 
dc.languageeng
 
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
 
dc.relation.ispartofJournal of Hepatology
 
dc.rightsJournal of Hepatology. Copyright © Elsevier BV.
 
dc.titleInterim report on a phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in Chinese patients with chronic hepatitis B infection
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Yuen, RMF</contributor.author>
<contributor.author>Kim, J</contributor.author>
<contributor.author>Wong, DKH</contributor.author>
<contributor.author>Ngai, WS</contributor.author>
<contributor.author>Yuen, JCH</contributor.author>
<contributor.author>Lai, CL</contributor.author>
<date.accessioned>2010-09-25T19:48:54Z</date.accessioned>
<date.available>2010-09-25T19:48:54Z</date.available>
<date.issued>2004</date.issued>
<identifier.citation>Journal of Hepatology, v. 40  n. suppl 1, p. 133</identifier.citation>
<identifier.issn>0168-8278</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/101419</identifier.uri>
<language>eng</language>
<publisher>Elsevier BV. The Journal&apos;s web site is located at http://www.elsevier.com/locate/jhep</publisher>
<relation.ispartof>Journal of Hepatology</relation.ispartof>
<rights>Journal of Hepatology. Copyright &#169; Elsevier BV.</rights>
<title>Interim report on a phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in Chinese patients with chronic hepatitis B infection</title>
<type>Conference_Paper</type>
<identifier.openurl>http://library.hku.hk:4550/resserv?sid=HKU:IR&amp;issn=0168-8278&amp;volume=40 &amp;issue=suppl 1&amp;spage=133&amp;epage=&amp;date=2004&amp;atitle=Interim+report+on+a+phase+I/IIa,+double-blind,+randomized,+placebo-controlled+trial+of+a+novel+antiviral+agent,+LB80380+in+Chinese+patients+with+chronic+hepatitis+B+infection</identifier.openurl>
<identifier.hkuros>130911</identifier.hkuros>
<identifier.volume>, v. 40  n. suppl 1</identifier.volume>
<identifier.issue>suppl 1</identifier.issue>
<identifier.spage>133</identifier.spage>
</item>